Mediclarum

ATC LAntineoplastic and immunomodulating agentsWHO

Cancer treatmentsand immune-system medicines

577 medicines · 335 active substances · from the European Medicines Agency — Medicines output: medicines report

Browse the substances How this group is made

Counted from the register

The group in figures

  • 577products listed in the register
  • 0%without prescription (0)
  • 9combination products — more than one substance

What the group contains

Anatomical main group L of the WHO ATC classification: “Antineoplastic and immunomodulating agents”. US records carry no ATC code: a product is here because the FDA pharmacologic class on its record maps to this group — not because of any judgement about who it is for.

186 marketing authorisation holders

  • L01 338
  • L04 171
  • L03 50
  • L02 18

ATC subgroups by code; their names are at the WHO index.

Source: European Medicines Agency — Medicines output: medicines report, 2026-09-30. Counts computed by Mediclarum from that file.

The most common
substances

ADALIMUMABUSTEKINUMABPEGFILGRASTIM161514

never combined
in one product

Each number is how many products in the register contain that substance.

Active substances in this group

Commonest first, by number of products in the register. Select one to see every product that contains it.

  1. 01Adalimumab16 productsprescription only
  2. 02Ustekinumab15 productsprescription only
  3. 03Pegfilgrastim14 productsprescription only
  4. 04Bevacizumab12 productsprescription only
  5. 05Pemetrexed12 productsprescription only
  6. 06Dimethyl fumarate10 productsprescription only
  7. 07Filgrastim10 productsprescription only
  8. 08Trastuzumab10 productsprescription only
  9. 09Docetaxel9 productsprescription only
  10. 10Rituximab9 productsprescription only
  11. 11Azacitidine7 productsprescription only
  12. 12Imatinib7 productsprescription only
  13. 13Temozolomide7 productsprescription only
  14. 14Topotecan7 productsprescription only
  15. 15Capecitabine6 productsprescription only
  16. 16Etanercept6 productsprescription only
  17. 17Leflunomide6 productsprescription only
  18. 18Lenalidomide6 productsprescription only
  19. 19Paclitaxel6 productsprescription only
  20. 20Pomalidomide6 productsprescription only
  21. 21Bortezomib5 productsprescription only
  22. 22Infliximab5 productsprescription only
  23. 23Tocilizumab5 productsprescription only
  24. 24Arsenic trioxide4 productsprescription only
  25. 25Mycophenolate mofetil4 productsprescription only
  26. 26Nintedanib4 productsprescription only
  27. 27Tacrolimus4 productsprescription only
  28. 28Dasatinib (anhydrous)3 productsprescription only
  29. 29Doxorubicin3 productsprescription only
  30. 30Eculizumab3 productsprescription only
  31. 31Enzalutamide3 productsprescription only
  32. 32Eribulin3 productsprescription only
  33. 33Fingolimod3 productsprescription only
  34. 34Golimumab3 productsprescription only
  35. 35Pirfenidone3 productsprescription only
  36. 36Teriflunomide3 productsprescription only
  37. 375-aminolevulinic acid hydrochloride2 productsprescription only
  38. 38Abiraterone2 productsprescription only
  39. 39Abiraterone acetate2 productsprescription only
  40. 40Alemtuzumab2 productsprescription only
  41. 41Alpelisib2 productsprescription only
  42. 42Anagrelide2 productsprescription only
  43. 43Apremilast2 productsprescription only
  44. 44Axitinib2 productsprescription only
  45. 45Belantamab mafodotin2 productsprescription only
  46. 46Busulfan2 productsprescription only
  47. 47Cabazitaxel2 productsprescription only
  48. 48Cabozantinib2 productsprescription only

Showing 48 of 331. Browse every substance A–Z

How this group is made

Each product is placed by the ATC code in its national register record (Bulgaria) or by the pharmacologic class the FDA assigned it (United States). Products without either are in no group rather than in a plausible one.

A group is not a diagnosis. Medicines are grouped by the class the regulator gave them. Which one suits you depends on things this page cannot know — ask a pharmacist or doctor.